Introduction
The immune-mediated inflammatory diseases (IMIDs) influence physical and mental state of the patients. Additionally, they affect greatly work productivity, not only by eliminating patients in productive age from the working population, but also influencing every-day work performance. The productivity loss, which is significant from the individual's perspective, can also be measured globally as a loss of benefit for the whole society. It could be expected that loss of productivity rises with severity of patient's condition. In case of autoimmune inflammatory diseases, it could be related to the severity of the inflammation episode. That is why it is important to control the intensity of episodes to minimize the productivity loss. The analysis of total indirect cost of a disease should be an important factor taken into consideration by health care policy makers. The aim of this presentation was to demonstrate the total indirect costs of RA, CD and Ps in an employed population in Poland and to show how differently indirect costs (namely costs of absenteeism and presenteeism) can be generated by each disease.
Methods
Data on presenteeism and absenteeism related with analyzed diagnoses were collected in a cross-sectional, multicenter, observational Polish study Move to Work. Patients in productive age (18-60 in case of women, 18-65 in case of men) with diagnosis of rheumatoid arthritis (RA), psoriasis (Ps) and Crohn's disease (CD) from 30 ambulatory rheumatology, 30 dermatology and 29 gastroenterology centers were invited to participate. Only the rheumatology and dermatology centers which had signed contract on ambulatory services with NHF were considered. The gastroenterology specialist centers were selected among the facilities which participated in the Polish Registry of Crohn's disease, with the exception of facilities which had registered less than 10 patients. Specialists included in the study were rheumatologists, dermatologists and gastroenterologists (one from each center) who have had minimum 5 years of experience and have consulted at least 10 patients weekly.
The Move to Work study took place from 15th November 2012 till 15th December 2012.
Loss of productivity was measured with a validated tool Work Productivity and Activity Impairment (WPAI) questionnaire, allowing to compare the productivity loss among the diseases. Patients' disease activity was assessed by practitioners using standardized, disease specific scales (DAS28, PASI, and CDAI).
For all diseases under consideration, analyses for absenteeism, presenteeism and overall work impairment rate were conducted. Additionally, statistical analyses in sub-groups (created in relation to disease activity -remission, low, moderate and high) were carried out. These analyses were based on nonparametric Kruskal-Wallis test to find any differences between independent samples (corresponding to subgroups). If the Kruskal-Wallis test prooved differences in sub-groups, then the U-Mann-Withney test was performed for each pair (to establish which of the analyzed sub-groups are responsible for the variability). Indirect costs were calculated for each disease for absenteeism, presenteeism and overall impairment separately, using GDP per worker per hour, which was equal to 12.49 EUR. Human capital method was adopted. A correction for diminishing marginal work productivity was applied (0.65). Statistical significance was set on 5%.
The average euro exchange rate in 31 December 2012 was assumed on the basis of the National Bank of Poland data (100 EUR = 408.82 PLN).
Indirect costs of diseases
According to results of M2W study, annual indirect costs per working person associated with overall work impairment due to analyzed illnesses varied from 5.8 thousand EUR (CD) to 7.2 thousand EUR (RA). Annual indirect costs per working person associated with absenteeism varied from 1.6 thousand EUR (Ps) and 3.2 thousand EUR (RA) and indirect costs associated with presenteeism -from 3.2 thousand EUR (CD) and 4.4 thousand EUR (Ps). It should be noticed that studied sample of CD patients had a rather low disease activity. This could be the reason of moderate indirect costs of CD despite the fact that CD symptoms in general are considered rather severe. However, costs of work productivity loss for patients with highly active CD were higher than for patients with highly active RA or psoriasis.
Costs associated with presenteeism for patients with psoriasis are more than two times higher than corresponding costs associated with absenteeism (4.4 and 1.6 thousand EUR respectively). In other diseases absenteeism and presenteeism costs are similar (presenteeism costs are slightly higher in each case).
Detailed values for indirect costs of analyzed diseases are presented in Figure 1 .
Analyzed diseases influence work ability in different ways -psoriasis caused the highest presenteeism, significant at every disease activity level, probably because its symptoms were highly distracting, but weren't severe enough to cause a lot of absenteeism. In case of CD and RA the absenteeism and presenteeism seemed to be equally significant. It could be noticed that absenteeism costs increase faster with higher disease activity than costs associated with presenteeism.
Annual indirect costs per working person with CD associated with overall work impairment rise with disease activity from 3.8 (remission) to 15.6 (high disease activity) thousand EUR. For patients with RA these costs rise from 3.7 to 10.1 thousand EUR respectively and for Ps patients -from 3.4 to 10.8 thousand EUR respectively. 
Human capital approach

GDP per worker the amount of goods and services (work in this case) produced within a country's borders in a specific time period per one worker. Indicator commonly used in the economy and relatively easy in application. The law of dimishing marginal productivity of production factors, which works in the economy, states that with the increase of a single factor of production, with other production factors staying constant, the decrease in marginal (incremental) output of production is noticed. Therefore, adjustment of results is needed (coefficient of 0.65 was applied).
Summary OBJECTIVES To assess the indirect costs of RA, CD and Ps in an employed population in Poland.
METHODS Data on presenteeism and absenteeism related with analyzed diagnoses were collected in a cross
Limitations
Absenteeism rates were calculated more objectively than presenteeism rates -parameters from the first group were measured by the number of working hours lost because of the illness. Presenteeism rates were assessed by questionnaire and answers could have been subjective (although there is no better way to assess presenteeism rate).
Only patients undergoing outpatient visits were included in the study. However, it seems that a significant proportion of people suffering from analyzed diseases in Poland is treated in hospitals or is not treated at all (e.g. Ps patients with low disease activity). Data on these groups were not collected.
The character of WPAI questions makes the WPAI questionnaire rather incompatible with the professional activity without determined work timeschedule (such as self-employed or product-oriented contracts). It may have been a cause of inaccuracy in results of the loss of productivity analysis for certain types of employment (e.g. farmers) and -in consequence -the indirect costs analysis.
Results
Characteristics of analyzed participants
From a total number of 2100 patients enrolled to M2W study, 1044 met established criteria* (256 CD patients, 460 Ps patients and 328 RA patients) and were analyzed for work productivity loss and indirect cost of mentioned diseases. Mean age of analyzed WPAI respondents was 36 for CD, 46 for RA and 42 for Ps patients (only patients in productive age -18-60/65 were included in the study). Mean age of total M2W population was similar (35, 48 and 42 respectively).
The average value of CDAI, measured in enrolled patients with Crohn's disease indicated low disease activity, but the most frequent disease activity category for CD patients was remission (39% and 38% respectively for population analyzed for productivity loss and total M2W population). The average value of DAS28 measured in enrolled patients with rheumatoid arthritis indicated moderate disease activity and in RA patients mostly (51% and 55% respectively) the moderate activity was observed. The average value of PASI, measured in enrolled patients with psoriasis indicated low/moderate disease activity. Ps patients had dominantly (54% and 52% respectively) low disease activity 9.8% of patients with psoriasis were also affected by psoriatic arthritis.
Summary of patients' characteristics (both for total M2W population and analyzed population) are shown in Table 1 . Worthy of note is the fact, that for each illness average disease activity is lower in working population than total population of the study. Greater number of patients from analyzed population than from total M2W population was classified to groups indicating remission or low disease activity. The opposite situation was observed for groups of patients with moderate or high disease activity.
